JPMorgan Chase & Co’s IDEAYA Biosciences IDYA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.38M | Buy |
446,420
+115,827
| +35% | +$2.43M | ﹤0.01% | 2267 |
|
|
2025
Q1 | $5.42M | Buy |
330,593
+55,900
| +20% | +$916K | ﹤0.01% | 2614 |
|
|
2024
Q4 | $7.06M | Buy |
274,693
+194,913
| +244% | +$5.01M | ﹤0.01% | 2507 |
|
|
2024
Q3 | $2.53M | Buy |
79,780
+12,029
| +18% | +$381K | ﹤0.01% | 3104 |
|
|
2024
Q2 | $2.38M | Sell |
67,751
-25,219
| -27% | -$885K | ﹤0.01% | 2982 |
|
|
2024
Q1 | $4.08M | Sell |
92,970
-23,528
| -20% | -$1.03M | ﹤0.01% | 2694 |
|
|
2023
Q4 | $4.14M | Buy |
116,498
+3,728
| +3% | +$133K | ﹤0.01% | 2687 |
|
|
2023
Q3 | $3.04M | Buy |
112,770
+2,209
| +2% | +$59.6K | ﹤0.01% | 2736 |
|
|
2023
Q2 | $2.6M | Buy |
110,561
+74,138
| +204% | +$1.74M | ﹤0.01% | 2886 |
|
|
2023
Q1 | $500K | Buy |
36,423
+8,434
| +30% | +$116K | ﹤0.01% | 3830 |
|
|
2022
Q4 | $509K | Buy |
27,989
+5,625
| +25% | +$102K | ﹤0.01% | 3739 |
|
|
2022
Q3 | $334K | Buy |
22,364
+1,309
| +6% | +$19.6K | ﹤0.01% | 3943 |
|
|
2022
Q2 | $291K | Buy |
21,055
+997
| +5% | +$13.8K | ﹤0.01% | 4155 |
|
|
2022
Q1 | $224K | Buy |
20,058
+3,870
| +24% | +$43.2K | ﹤0.01% | 4386 |
|
|
2021
Q4 | $383K | Sell |
16,188
-8,594
| -35% | -$203K | ﹤0.01% | 4212 |
|
|
2021
Q3 | $632K | Buy |
24,782
+4,945
| +25% | +$126K | ﹤0.01% | 3844 |
|
|
2021
Q2 | $416K | Sell |
19,837
-12,013
| -38% | -$252K | ﹤0.01% | 4101 |
|
|
2021
Q1 | $749K | Sell |
31,850
-44,840
| -58% | -$1.05M | ﹤0.01% | 3819 |
|
|
2020
Q4 | $1.07M | Buy |
76,690
+60,296
| +368% | +$844K | ﹤0.01% | 3339 |
|
|
2020
Q3 | $194K | Buy |
16,394
+12,349
| +305% | +$146K | ﹤0.01% | 3747 |
|
|
2020
Q2 | $57K | Buy |
+4,045
| New | +$57K | ﹤0.01% | 4179 |
|